{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:58:35Z","timestamp":1786132715929,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1681\/asn.2013010060","type":"journal-article","created":{"date-parts":[[2013,8,9]],"date-time":"2013-08-09T02:14:49Z","timestamp":1376014489000},"page":"1782-1792","source":"Crossref","is-referenced-by-count":27,"title":["Genetic Deletion of Cell Division Autoantigen 1 Retards Diabetes-Associated Renal Injury"],"prefix":"10.1681","volume":"24","author":[{"given":"Zhonglin","family":"Chai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aozhi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugang","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaze","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tieqiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna J.","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Koentgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merlin C.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20230208","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1681\/ASN.2007020220","article-title":"End-stage renal disease in the United States: An update from the United States Renal Data System.","volume":"18","author":"Foley","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R2-12-20230208","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0272-6386(99)70035-1","article-title":"End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions.","volume":"34","author":"Ritz","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R3-12-20230208","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/S0270-9295(03)00132-3","article-title":"Diabetic nephropathy and transforming growth factor-beta: Transforming our view of glomerulosclerosis and fibrosis build-up.","volume":"23","author":"Chen","year":"2003","journal-title":"Semin Nephrol"},{"key":"R4-12-20230208","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2337\/db08-0061","article-title":"From fibrosis to sclerosis: Mechanisms of glomerulosclerosis in diabetic nephropathy.","volume":"57","author":"Qian","year":"2008","journal-title":"Diabetes"},{"key":"R5-12-20230208","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1172\/JCI11951","article-title":"Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE).","volume":"108","author":"Oldfield","year":"2001","journal-title":"J Clin Invest"},{"key":"R6-12-20230208","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1523-1755.2004.00367.x","article-title":"Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury.","volume":"65","author":"Chow","year":"2004","journal-title":"Kidney Int"},{"key":"R7-12-20230208","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/01.ASN.0000065640.77499.D7","article-title":"Extracellular matrix metabolism in diabetic nephropathy.","volume":"14","author":"Mason","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R8-12-20230208","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1073\/pnas.90.5.1814","article-title":"Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.","volume":"90","author":"Yamamoto","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-12-20230208","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1681\/ASN.2006050525","article-title":"Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: Implications for diabetic renal disease.","volume":"17","author":"Burns","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R10-12-20230208","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.2337\/diacare.25.6.1072","article-title":"Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: Effects of angiotensin receptor blockade and sodium restriction.","volume":"25","author":"Houlihan","year":"2002","journal-title":"Diabetes Care"},{"key":"R11-12-20230208","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1073\/pnas.120055097","article-title":"Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db\/db diabetic mice.","volume":"97","author":"Ziyadeh","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-12-20230208","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.ki.5002717","article-title":"Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis.","volume":"73","author":"Petersen","year":"2008","journal-title":"Kidney Int"},{"key":"R13-12-20230208","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1073\/pnas.90.2.770","article-title":"Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.","volume":"90","author":"Kulkarni","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R14-12-20230208","first-page":"3","article-title":"Transforming growth factor-beta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease.","volume":"143","author":"Kulkarni","year":"1993","journal-title":"Am J Pathol"},{"key":"R15-12-20230208","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1242\/dev.121.6.1845","article-title":"Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice.","volume":"121","author":"Dickson","year":"1995","journal-title":"Development"},{"key":"R16-12-20230208","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1093\/emboj\/20.7.1663","article-title":"Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice.","volume":"20","author":"Larsson","year":"2001","journal-title":"EMBO J"},{"key":"R17-12-20230208","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.4049\/jimmunol.153.5.1936","article-title":"Immune dysregulation in TGF-beta 1-deficient mice.","volume":"153","author":"Christ","year":"1994","journal-title":"J Immunol"},{"key":"R18-12-20230208","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/359693a0","article-title":"Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.","volume":"359","author":"Shull","year":"1992","journal-title":"Nature"},{"key":"R19-12-20230208","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ki.2010.374","article-title":"Cell division autoantigen 1 enhances signaling and the profibrotic effects of transforming growth factor-\u03b2 in diabetic nephropathy.","volume":"79","author":"Tu","year":"2011","journal-title":"Kidney Int"},{"key":"R20-12-20230208","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00125-009-1555-9","article-title":"Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosis.","volume":"53","author":"Pham","year":"2010","journal-title":"Diabetologia"},{"key":"R21-12-20230208","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1681\/ASN.2004050392","article-title":"Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice.","volume":"16","author":"Lassila","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R22-12-20230208","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1097\/01.ASN.0000133025.23732.46","article-title":"Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: Role of advanced glycation end products.","volume":"15","author":"Lassila","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R23-12-20230208","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1046\/j.1523-1755.2003.00016.x","article-title":"Role of TGF-beta signaling in extracellular matrix production under high glucose conditions.","volume":"63","author":"Li","year":"2003","journal-title":"Kidney Int"},{"key":"R24-12-20230208","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/01.CIR.0000165133.84978.E2","article-title":"Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism.","volume":"111","author":"Rodr\u00edguez-Vita","year":"2005","journal-title":"Circulation"},{"key":"R25-12-20230208","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.0000089129.51288.BA","article-title":"Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis.","volume":"108","author":"Rup\u00e9rez","year":"2003","journal-title":"Circulation"},{"key":"R26-12-20230208","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1096\/fj.02-1117fje","article-title":"Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: Implications for diabetic renal and vascular disease.","volume":"18","author":"Li","year":"2004","journal-title":"FASEB J"},{"key":"R27-12-20230208","doi-asserted-by":"crossref","first-page":"33665","DOI":"10.1074\/jbc.M007681200","article-title":"SET-related cell division autoantigen-1 (CDA1) arrests cell growth.","volume":"276","author":"Chai","year":"2001","journal-title":"J Biol Chem"},{"key":"R28-12-20230208","doi-asserted-by":"crossref","first-page":"e51555","DOI":"10.1371\/journal.pone.0051555","article-title":"Identification of novel interacting partners of Sirtuin6.","volume":"7","author":"Polyakova","year":"2012","journal-title":"PLoS One"},{"key":"R29-12-20230208","doi-asserted-by":"crossref","first-page":"L391","DOI":"10.1152\/ajplung.00097.2010","article-title":"Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-\u03b2-induced senescence of human bronchial epithelial cells.","volume":"300","author":"Minagawa","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R30-12-20230208","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2353\/ajpath.2006.050921","article-title":"ERK, p38, and Smad signaling pathways differentially regulate transforming growth factor-beta1 autoinduction in proximal tubular epithelial cells.","volume":"169","author":"Zhang","year":"2006","journal-title":"Am J Pathol"},{"key":"R31-12-20230208","doi-asserted-by":"crossref","first-page":"F1657","DOI":"10.1152\/ajprenal.00274.2007","article-title":"Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.","volume":"293","author":"Wang","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"R32-12-20230208","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1523-1755.2004.00600.x","article-title":"Utility of endogenous creatinine clearance as a measure of renal function in mice.","volume":"65","author":"Dunn","year":"2004","journal-title":"Kidney Int"},{"key":"R33-12-20230208","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.2337\/db07-1808","article-title":"Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes.","volume":"57","author":"Soro-Paavonen","year":"2008","journal-title":"Diabetes"},{"key":"R34-12-20230208","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1523-1755.1998.00019.x","article-title":"A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR).","volume":"54","author":"Kelly","year":"1998","journal-title":"Kidney Int"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201311000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:23:09Z","timestamp":1786130589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201311000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2013010060","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}